Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Galena pays $10M upfront to license Abstral, a treatment for severe episodes of cancer pain
Galena pays $10M upfront to license Abstral, a treatment for severe episodes of cancer pain
Galena pays $10M upfront to license Abstral, a treatment for severe episodes of cancer pain
Submitted by
admin
on March 18, 2013 - 11:09am
Source:
Yahoo/AP
News Tags:
Galena Biopharma
Abstral
cancer pain
Orexo
Headline:
Galena pays $10M upfront to license Abstral, a treatment for severe episodes of cancer pain
Do Not Allow Advertisers to Use My Personal information
